SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-23-009271
Filing Date
2023-07-17
Accepted
2023-07-17 16:05:30
Documents
1
Period of Report
2023-07-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 1382
  Complete submission text file 0001654954-23-009271.txt   2813
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 SPY COURT C/O EDESA BIOTECH, INC. MARKHAM A6 L3R 5H6
Business Address
Lemieux Stephen (Reporting) CIK: 0001983036 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37619 | Film No.: 231091685